BofA Below Consensus on AstraZeneca (AZN), Still a Top Pick
Tweet Send to a Friend
BofA analyst Sachin Jain on AstraZeneca (NASDAQ: AZN): "We forecast 3Q core EPS of $1.44, +34% YoY, c5% below consensus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE